Produits chimiques et pharmaceutiques : Questions médicales fréquentes
Nom anglais: Chemicals and Drugs
Descriptor UI:MD
Tree Number:D
Termes MeSH sélectionnés :
Pilot Projects
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Produits chimiques et pharmaceutiques : Questions médicales les plus fréquentes",
"headline": "Produits chimiques et pharmaceutiques : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Produits chimiques et pharmaceutiques : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-06-19",
"dateModified": "2025-03-16",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Produits chimiques et pharmaceutiques"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"about": {
"@type": "MedicalCondition",
"name": "Produits chimiques et pharmaceutiques",
"alternateName": "Chemicals and Drugs",
"code": {
"@type": "MedicalCode",
"code": "MD",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Nicolas Simon",
"url": "https://questionsmedicales.fr/author/Nicolas%20Simon",
"affiliation": {
"@type": "Organization",
"name": "Pharmacy, Geneva University Hospitals and School of Pharmaceutical Sciences, University of Geneva, University of Lausanne, Geneva, Switzerland."
}
},
{
"@type": "Person",
"name": "Pascal Odou",
"url": "https://questionsmedicales.fr/author/Pascal%20Odou",
"affiliation": {
"@type": "Organization",
"name": "Univ. Lille, CHU Lille, EA 7365-GRITA-Groupe de Recherche sur les Formes Injectables et les Technologies Associées, Lille, France."
}
},
{
"@type": "Person",
"name": "José L Medina-Franco",
"url": "https://questionsmedicales.fr/author/Jos%C3%A9%20L%20Medina-Franco",
"affiliation": {
"@type": "Organization",
"name": "DIFACQUIM Research Group, Department of Pharmacy, School of Chemistry, Universidad Nacional Autónoma de México, Mexico City, Mexico."
}
},
{
"@type": "Person",
"name": "Hongbin Yang",
"url": "https://questionsmedicales.fr/author/Hongbin%20Yang",
"affiliation": {
"@type": "Organization",
"name": "Yusuf Hamied Department of Chemistry, University of Cambridge, Lensfield Road, CB2 1EW, Cambridge, United Kingdom."
}
},
{
"@type": "Person",
"name": "Chiara Borsari",
"url": "https://questionsmedicales.fr/author/Chiara%20Borsari",
"affiliation": {
"@type": "Organization",
"name": "Department of Biomedicine, University of Basel, Mattenstrasse 28, 4058 Basel, Switzerland."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Service Demand for and Awareness of a Primary Healthcare Pilot Project for People With Disabilities.",
"datePublished": "2022-08-01",
"url": "https://questionsmedicales.fr/article/35916049",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3346/jkms.2022.37.e241"
}
},
{
"@type": "ScholarlyArticle",
"name": "[The KomMent study: a pilot project on structured interprofessional communication in uro-oncology].",
"datePublished": "2022-10-07",
"url": "https://questionsmedicales.fr/article/36205744",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00120-022-01945-x"
}
},
{
"@type": "ScholarlyArticle",
"name": "[Psychiatric-Psychotherapeutic Care in Crisis: Results of the LeiP#Netz Pilot Project].",
"datePublished": "2022-11-25",
"url": "https://questionsmedicales.fr/article/36427493",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1055/a-1902-6326"
}
},
{
"@type": "ScholarlyArticle",
"name": "Adaptation of Screening Tools for Social Determinants of Health in Pregnancy: A Pilot Project.",
"datePublished": "2023-06-14",
"url": "https://questionsmedicales.fr/article/37316688",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s10995-023-03732-2"
}
},
{
"@type": "ScholarlyArticle",
"name": "Colorectal Cancer Screening Pilot Project in Tehran-Iran, a Feasibility Study.",
"datePublished": "2023-03-01",
"url": "https://questionsmedicales.fr/article/37543936",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.34172/aim.2023.22"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Produits chimiques et pharmaceutiques",
"item": "https://questionsmedicales.fr/mesh/MD"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Produits chimiques et pharmaceutiques - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Produits chimiques et pharmaceutiques",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-11",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Produits chimiques et pharmaceutiques",
"description": "Comment les médicaments sont-ils testés avant leur approbation ?\nQu'est-ce qu'un test de toxicité ?\nQuels sont les biomarqueurs utilisés en pharmacologie ?\nComment évaluer l'efficacité d'un médicament ?\nQu'est-ce qu'une interaction médicamenteuse ?",
"url": "https://questionsmedicales.fr/mesh/MD?mesh_terms=Pilot+Projects&page=2#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Produits chimiques et pharmaceutiques",
"description": "Quels symptômes peuvent indiquer une intoxication médicamenteuse ?\nComment reconnaître une réaction allergique à un médicament ?\nQuels sont les effets secondaires courants des antibiotiques ?\nQuels symptômes indiquent un surdosage ?\nComment identifier une dépendance à un médicament ?",
"url": "https://questionsmedicales.fr/mesh/MD?mesh_terms=Pilot+Projects&page=2#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Produits chimiques et pharmaceutiques",
"description": "Comment prévenir les effets secondaires des médicaments ?\nQuels vaccins sont considérés comme des produits pharmaceutiques ?\nComment réduire le risque d'interactions médicamenteuses ?\nQuelles sont les mesures préventives pour éviter les infections ?\nComment la recherche contribue-t-elle à la prévention des maladies ?",
"url": "https://questionsmedicales.fr/mesh/MD?mesh_terms=Pilot+Projects&page=2#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Produits chimiques et pharmaceutiques",
"description": "Quels sont les traitements pour une surdose médicamenteuse ?\nComment les médicaments sont-ils administrés ?\nQu'est-ce que la thérapie génique ?\nQuels sont les traitements pour les infections bactériennes ?\nComment les médicaments anticancéreux fonctionnent-ils ?",
"url": "https://questionsmedicales.fr/mesh/MD?mesh_terms=Pilot+Projects&page=2#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Produits chimiques et pharmaceutiques",
"description": "Quelles complications peuvent survenir avec les antibiotiques ?\nQuels sont les risques d'une surdose médicamenteuse ?\nComment les médicaments peuvent-ils affecter la grossesse ?\nQuelles complications peuvent résulter d'un traitement prolongé ?\nQuels sont les effets à long terme des médicaments psychotropes ?",
"url": "https://questionsmedicales.fr/mesh/MD?mesh_terms=Pilot+Projects&page=2#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Produits chimiques et pharmaceutiques",
"description": "Quels facteurs augmentent le risque d'effets secondaires ?\nComment l'usage de médicaments peut-il varier selon l'âge ?\nQuels comportements augmentent le risque de dépendance ?\nComment les antécédents familiaux influencent-ils le risque médicamenteux ?\nQuels facteurs environnementaux influencent l'usage des médicaments ?",
"url": "https://questionsmedicales.fr/mesh/MD?mesh_terms=Pilot+Projects&page=2#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment les médicaments sont-ils testés avant leur approbation ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les médicaments subissent des essais cliniques en plusieurs phases pour évaluer leur sécurité et efficacité."
}
},
{
"@type": "Question",
"name": "Qu'est-ce qu'un test de toxicité ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un test de toxicité évalue les effets nocifs d'une substance chimique sur des organismes vivants."
}
},
{
"@type": "Question",
"name": "Quels sont les biomarqueurs utilisés en pharmacologie ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les biomarqueurs sont des indicateurs biologiques mesurables de l'effet d'un médicament sur l'organisme."
}
},
{
"@type": "Question",
"name": "Comment évaluer l'efficacité d'un médicament ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'efficacité est évaluée par des études cliniques comparant le médicament à un placebo ou à un traitement standard."
}
},
{
"@type": "Question",
"name": "Qu'est-ce qu'une interaction médicamenteuse ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une interaction médicamenteuse se produit lorsque deux médicaments affectent mutuellement leur efficacité ou sécurité."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent indiquer une intoxication médicamenteuse ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent nausées, vomissements, confusion, et troubles respiratoires."
}
},
{
"@type": "Question",
"name": "Comment reconnaître une réaction allergique à un médicament ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les réactions allergiques peuvent se manifester par des éruptions cutanées, démangeaisons ou œdème."
}
},
{
"@type": "Question",
"name": "Quels sont les effets secondaires courants des antibiotiques ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires incluent diarrhée, nausées, et réactions allergiques."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent un surdosage ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes de surdosage varient selon le médicament, mais peuvent inclure confusion et troubles cardiaques."
}
},
{
"@type": "Question",
"name": "Comment identifier une dépendance à un médicament ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent un besoin compulsif de la substance, des symptômes de sevrage et des comportements de recherche."
}
},
{
"@type": "Question",
"name": "Comment prévenir les effets secondaires des médicaments ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention inclut une prescription appropriée, une surveillance et l'éducation des patients."
}
},
{
"@type": "Question",
"name": "Quels vaccins sont considérés comme des produits pharmaceutiques ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les vaccins contre la grippe, l'hépatite et le tétanos sont des exemples de produits pharmaceutiques préventifs."
}
},
{
"@type": "Question",
"name": "Comment réduire le risque d'interactions médicamenteuses ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il est essentiel de consulter un professionnel de santé avant de prendre plusieurs médicaments."
}
},
{
"@type": "Question",
"name": "Quelles sont les mesures préventives pour éviter les infections ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les mesures incluent la vaccination, l'hygiène et l'utilisation prudente des antibiotiques."
}
},
{
"@type": "Question",
"name": "Comment la recherche contribue-t-elle à la prévention des maladies ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "La recherche développe de nouveaux médicaments et stratégies pour prévenir et traiter les maladies."
}
},
{
"@type": "Question",
"name": "Quels sont les traitements pour une surdose médicamenteuse ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement peut inclure l'administration d'antidotes, le lavage gastrique ou des soins de soutien."
}
},
{
"@type": "Question",
"name": "Comment les médicaments sont-ils administrés ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les médicaments peuvent être administrés par voie orale, intraveineuse, topique ou inhalée."
}
},
{
"@type": "Question",
"name": "Qu'est-ce que la thérapie génique ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "La thérapie génique utilise des médicaments pour traiter des maladies en modifiant les gènes défectueux."
}
},
{
"@type": "Question",
"name": "Quels sont les traitements pour les infections bactériennes ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les infections bactériennes sont généralement traitées avec des antibiotiques spécifiques."
}
},
{
"@type": "Question",
"name": "Comment les médicaments anticancéreux fonctionnent-ils ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils ciblent les cellules cancéreuses pour inhiber leur croissance ou provoquer leur mort."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec les antibiotiques ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des infections fongiques, des réactions allergiques et des résistances."
}
},
{
"@type": "Question",
"name": "Quels sont les risques d'une surdose médicamenteuse ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les risques incluent des lésions organiques, des troubles neurologiques et la mort."
}
},
{
"@type": "Question",
"name": "Comment les médicaments peuvent-ils affecter la grossesse ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains médicaments peuvent causer des malformations congénitales ou des complications pendant la grossesse."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent résulter d'un traitement prolongé ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des effets secondaires chroniques et des dépendances."
}
},
{
"@type": "Question",
"name": "Quels sont les effets à long terme des médicaments psychotropes ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets à long terme peuvent inclure des troubles cognitifs, des dépendances et des effets sur l'humeur."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque d'effets secondaires ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'âge, le poids, les maladies préexistantes et les interactions médicamenteuses augmentent le risque."
}
},
{
"@type": "Question",
"name": "Comment l'usage de médicaments peut-il varier selon l'âge ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les personnes âgées peuvent être plus sensibles aux effets des médicaments en raison de changements physiologiques."
}
},
{
"@type": "Question",
"name": "Quels comportements augmentent le risque de dépendance ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'usage récréatif, l'automédication et l'absence de suivi médical augmentent le risque de dépendance."
}
},
{
"@type": "Question",
"name": "Comment les antécédents familiaux influencent-ils le risque médicamenteux ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents familiaux de maladies peuvent prédisposer à des réactions indésirables aux médicaments."
}
},
{
"@type": "Question",
"name": "Quels facteurs environnementaux influencent l'usage des médicaments ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'accès aux soins, la culture et l'éducation influencent l'usage et la prescription des médicaments."
}
}
]
}
]
}
This study investigated the demand for and awareness of a primary healthcare pilot project for people with disabilities; it also sought to identify relevant determinants for demand and awareness using...
This study is a secondary analysis of data from the population-based survey conducted in Gyeonggi Regional Health & Medical Center for People with Disabilities. The data was designed with quota ra...
Awareness of the service (12.1%) was remarkably low, while the demand (80.5%) was high. The gap between respondents who needed the service but were unaware of it differed according to age, education, ...
Chronic disease and an unmet need for medical care were key determinants of service demand, while the severity of disability was not. Thus, there is a need to review the initiative that defines servic...
Communication and interprofessional collaboration with patients diagnosed with cancer is challenging. Structured communication training has not yet been integrated into postgraduate medical education....
A needs assessment was conducted using focus groups and individual interviews. Learning objectives were aligned with (inter)national learning objective catalogs. The ICT was developed using the six-st...
Physician participation rates in the workshops were 83.0% and nursing participation rates were 58.3%. Utilization of the workplace-based training was 97%. The physicians evaluated the ICT very positiv...
The implementation of an ICT with 80 teaching units is successfully feasible in a urological clinic and leads to a sustainable improvement of the communication culture, among other things through ment...
Analysis of psychiatric-psychotherapeutic crisis services in the Leipzig Psychiatry Network (LeiP#netz), assigning the services to the functional areas of the FBM according to Steinhart and Wienberg....
A standardized survey of crisis care was conducted using the functions "complex outpatient treatment", "access to acute psychotherapy in crisis", and "24 h complex, intensive treatment" by means of fa...
A total of 31 measures were recorded for the three functions. All crisis care services were highly utilized; in up to one-third of cases, no services could be provided when demand was requested. Servi...
Crisis care services for severely mentally ill people are available in various constellations in the study region. Low-threshold 24/7 crisis services need to be expanded....
Social determinants of health (SDOH) and stress during pregnancy may contribute to adverse pregnancy outcomes. The objective of this in the field pilot project was to develop a comprehensive screening...
Pregnant patients accessing prenatal care at a single site of an urban Federally Qualified Health Center were recruited during prenatal visits to complete a Social Determinants of Health in Pregnancy ...
Between April 2018 and March 2019, 135 pregnant participants completed SIPT. Ninety-one percent of patients scored positive on at least one screener, 54% to three or more screeners....
Despite guidelines to screen for SDOH during pregnancy there is no universal tool. Our pilot project demonstrated the concurrent use of adapted screening tools where participants reported at least one...
Colorectal cancer (CRC) is the third most common cancer in Iran, where there is no organised CRC-screening programme. This study aimed to evaluate feasibility of CRC screening using a qualitative feca...
In this feasibility study, 7039 individuals aged 50-75 years were invited by community health workers (CHWs) in southern Tehran and its suburban districts between April 2018 and November 2019. The CHW...
Acceptance rate at initial invitation was 71.7%. From 4974 average-risk adults (1600 males and 3374 females) who were offered FIT, 96.8% (n=4813) provided valid samples, of whom 471 (9.8%) tested posi...
Our results partially support the feasibility of scaling up organized CRC-screening through the existing healthcare system in Iran; it remains to be discussed carefully to ensure the capacity of healt...
Evidence synthesis organisations are trying to meet commissioners' needs for rapid responses to their evidence synthesis commissions. In this project we piloted an intensive process, working to comple...
In a pre-planning phase, an intensive work group was established, and two commissions were selected for this pilot project. The evidence synthesis process was divided into two phases: planning and int...
During the planning phase, teams identified significant uncertainties regarding scopes, research questions, and inclusion criteria. To address this, they engaged with commissioners earlier than origin...
Overall, the intensive process fostered focus and productivity, allowing teams to manage short-term deliverables effectively. The researchers preferred working intensively with one evidence synthesis ...
Families with one parent suffering from cancer are exposed to extraordinary emotional and organizational burdens, affecting underaged children. To help coordinated access to social and logistic suppor...
A cross-sectional observational study was conducted using a mixed-method approach. Semi-structured written expert surveys (n=10) and secondary analysis of routine data of the care model (n=171 familie...
Quantitative secondary analysis: The participating families had 1-7 children (median (m) 2, range (s) 6). In 66% of the cases, the mother was affected by cancer, in 20% the diseased parent was in a si...
The data collected indicate that in families, matching the German average in their socio-demographic characteristics, a great need for organizational support develops as soon as one parent becomes sic...
We initiate the Westlake BioBank for Chinese (WBBC) pilot project with 4,535 whole-genome sequencing (WGS) individuals and 5,841 high-density genotyping individuals, and identify 81.5 million SNPs and...
To report a pilot project of expert nurses for outpatient parenteral antimicrobial treatment (OPAT) follow-up....
Three nurses with specific training on antibiotics started a state-funded programme including: i) consultations for OPAT follow-up; ii) hotline for satellite hospitals; iii) peer training. Patients' d...
From December 2020 to December 2021, 118 patients (median age 66.5 years [52-75], male-to-female ratio 2.5) were enrolled, for a total of 621 consultations. Patients were mostly on OPAT for bone and j...
Nurses may be important actors for OPAT follow-up....
The Fellowship Council (FC) is transitioning to a competency-based medical education (CBME) model, including the introduction of Entrustable Professional Activities (EPAs) for training and assessment ...
The FC coordinated the development of EPAs in collaboration with the sponsoring societies for Advanced GI/MIS, Bariatrics, Foregut, Endoscopy and Hepatopancreaticobiliary (HPB) fellowships encompassin...
The 15 participating programs included 18 fellows and 106 faculty. A total of 655 assessments were initiated with 429 (65%) completed. The average (SD) number of EPAs completed for each fellow was 24(...
A competency-based assessment framework was developed by the FC and piloted in several programs. Participation was variable and required ongoing strategies to address barriers. The pilot project has p...